News | November 13, 2014

Nico Corp. and Synaptive Medical Partner to Improve Neurosurgery Visualization

Agreement allows Nico to act as sales agent for Synaptive Medical in the United States

November 13, 2014 — Indianapolis interventional medical device maker Nico Corporation and Toronto-based Synaptive Medical announced at the Congress of Neurological Surgeons Annual Meeting that they have joined forces to integrate their innovative technologies for brain surgery. Nico's BrainPath interventional access technology and Synaptive's BrightMatter real-time 3-D visualization and planning system are the foundation of a unique sales agreement that enables the two companies to improve market penetration and also bring an integrated surgery solution to neurosurgeons and the patient population.

The collaboration between Nico and Synaptive is an agreement that allows Nico to act as a United States sales agent for Synaptive Medical. Nico currently has 20 field team representatives throughout the United States. Nearly 200 neurosurgeons have been trained on the BrainPath surgical approach through concentrated education courses and over 1,000 successful surgeries have been performed. Clinical and scientific evidence is building with peer-reviewed publications, 9 peer-reviewed abstracts and case studies presented or published validating the clinical and patient outcomes using BrainPath.

In this time of advanced technology and once-complicated surgeries moving to minimally invasive approaches, truly replicating this standard of care in neurosurgery remains one of the final frontiers. The move is similar to what happened in orthopedics when the specialty went from performing open knee surgery that required weeks of recovery time to arthroscopic surgery that is done today in which patients recover in much shorter times and with less trauma.

The patented BrainPath provides unique surgical access to brain abnormalities and atraumatically accesses emergent and hard-to-reach brain lesions that were considered inoperable or inaccessible. It is designed to minimize tissue damage by displacing tissues of the brain during advancement to the abnormality – much like the way a boat hull moves through water by displacing what is in front of it – all through an opening smaller than a dime. The outer sheath remains in the brain to serve as a protective portal for surgeons to easily maintain access to the surgical site during tissue removal or fluid evacuation.

BrightMatter products provide advanced visualization and planning tools that enable pre-operative planning for image-guided treatments. Using automated data processing that allows for brain segmentation and hands-free imaging registration to generate real-time 3-D tractography, the BrightMatter workflow approach fuses tractography with the area of interest to plan a simple and intuitive trajectory for the BrainPath intervention technology. The BrainPath provides a pathway for tissue removal tools, which enables resection of abnormalities.

This is not the first time Nico and Synaptive have joined their company technologies to create a new market and change a standard of patient care. In 2004, the two partnered under Sentinelle Medical and Suros Surgical Systems to make breast biopsy for high-risk women possible while in the magnetic resonance imaging (MRI) suite. This combination of imaging and intervention made diagnosing breast lesions as malignant or benign possible prior to mastectomy for women in this high-risk category. Both companies were later acquired by Hologic Inc.

For more information: www.niconeuro.com, www.synaptivemedical.com

Related Content

Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Charles Ananian, M.D.

Charles Ananian, M.D.

Sponsored Content | Case Study | Digital Radiography (DR) | November 07, 2018
Whether it’s a premature baby or a critically ill child, treating little patients is a huge responsibility.
Results of the vertebrae-based analysis (383 vertebrae in 34 patients) for detection of BME.

Results of the vertebrae-based analysis (383 vertebrae in 34 patients) for detection of BME.

Sponsored Content | Case Study | Computed Tomography (CT) | November 06, 2018
The following is a summary of a study published in the
An example of the newest generation of smart cardiac CT software that automatically identifies the anatomy, autotraces the centerlines on the entire coronary tree and labels each vessel segment.

An example of the newest generation of smart cardiac CT software that automatically identifies the anatomy, autotraces the centerlines on the entire coronary tree and labels each vessel segment. This greatly speeds CT workflows, saving time for techs, radiologists and cardiologists.

Feature | Radiology Imaging | October 04, 2018 | By Dave Fornell
Here is a checklist of dose-sparing practices for cardiac computed tomography (CT) imaging used in the cath lab.
Philips Launches Ingenia Ambition X 1.5T MR
News | Magnetic Resonance Imaging (MRI) | September 14, 2018
September 14, 2018 — Philips announced the launch of the Ingenia Ambition X 1.5T...
Videos | Radiation Therapy | September 07, 2018
A discussion with Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke University Clinical Imaging Physics Gr
Videos | Radiomics | August 09, 2018
A discussion with Martin Vallieres, Ph.D., post-doctoral fellow at McGill University, Montreal, Canada.
Gary D. Luker Named Editor of Radiology: Imaging Cancer

Image courtesy of University of Michigan Medical School

News | Oncology Diagnostics | August 06, 2018
The Board of Directors of the Radiological Society of North America (RSNA) announced that Gary D. Luker, M.D., will...
Videos | Digital Radiography (DR) | August 03, 2018
Sheila Sferrella, president of Regents Health Resources and Bill Finerfrock, president of Capitol Associates, discuss
Videos | AAPM | August 03, 2018
Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke Un...